Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Calcium antagonist shown to cause left ventricular hypertrophy regression

April 30, 1997

Roche discloses human renin inhibitors

April 30, 1997

Kissei prepares smooth muscle cell proliferation inhibitors

April 30, 1997

Novel cardiac antiischemic agents disclosed by Kanebo

April 30, 1997

Endothelin antagonists reported by Kowa

April 30, 1997

Neurex's blood pressure treatment up for FDA advisory panel review in June

April 29, 1997

NOS inhibitors disclosed by Searle

April 29, 1997

FDA approves new labeling for Bristol-Myers Squibb's Pravachol

April 29, 1997

Angiotensin II antagonist effective for progression of diabetic nephropathy

April 29, 1997

Xoma and Pfizer discontinue U.S. phase III trial of E5

April 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...